229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.05%
Negative revenue growth while VUZI stands at 11.92%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-16.60%
Negative gross profit growth while VUZI is at 11.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-21.37%
Negative EBIT growth while VUZI is at 12.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-21.37%
Negative operating income growth while VUZI is at 12.00%. Joel Greenblatt would press for urgent turnaround measures.
-19.46%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-19.05%
Negative EPS growth while VUZI is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-19.15%
Negative diluted EPS growth while VUZI is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.66%
Share reduction while VUZI is at 0.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.68%
Reduced diluted shares while VUZI is at 0.02%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-2.48%
Dividend reduction while VUZI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-16.01%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-15.14%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
262.47%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
97.49%
Positive 5Y CAGR while VUZI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
79.66%
Positive 3Y CAGR while VUZI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
280.64%
10Y OCF/share CAGR above 1.5x VUZI's 7.96%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
140.33%
5Y OCF/share CAGR above 1.5x VUZI's 45.51%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
137.03%
3Y OCF/share CAGR above 1.5x VUZI's 2.56%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
321.74%
Net income/share CAGR above 1.5x VUZI's 69.56% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
122.54%
5Y net income/share CAGR above 1.5x VUZI's 36.42%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
137.27%
Positive short-term CAGR while VUZI is negative. John Neff would see a clear advantage in near-term profit trajectory.
-23.55%
Negative equity/share CAGR over 10 years while VUZI stands at 166.37%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-37.63%
Negative 5Y equity/share growth while VUZI is at 14.85%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-12.44%
Negative 3Y equity/share growth while VUZI is at 127.70%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
144.19%
Dividend/share CAGR of 144.19% while VUZI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
45.67%
Dividend/share CAGR of 45.67% while VUZI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
19.47%
3Y dividend/share CAGR of 19.47% while VUZI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-33.74%
Firm’s AR is declining while VUZI shows 84.38%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
9.71%
Inventory growth well above VUZI's 0.08%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-4.21%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
10.31%
Positive BV/share change while VUZI is negative. John Neff sees a clear edge over a competitor losing equity.
-1.35%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-3.27%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-6.14%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.
